Mazama Capital Management’s Halozyme HALO Stock Holding History

Mazama Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-177,034	Closed	-$3.07M	–	72
2015 Q4	$3.07M	Buy	177,034 +64,923	+58%	+$1.03M	0.56%	55
2015 Q3	$1.51M	Sell	112,111 -23,608	-17%	-$474K	0.31%	79
2015 Q2	$3.06M	Sell	135,719 -10,304	-7%	-$181K	0.62%	51
2015 Q1	$2.08M	Sell	146,023 -212,064	-59%	-$3.06M	0.43%	75
2014 Q4	$3.46M	Buy	358,087 +268,037	+298%	+$2.38M	0.79%	42
2014 Q3	$819K	Buy	90,050 +84,552	+1,538%	+$805K	0.21%	135
2014 Q2	$54K	Buy	+5,498	New	+$46.6K	0.01%	214
2013 Q4	–	Sell	-5,359	Closed	-$59K	–	261
2013 Q3	$59K	Sell	5,359 -2,852	-35%	-$23.8K	0.03%	149
2013 Q2	$65K	Buy	+8,211	New	+$52.3K	0.04%	142

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Mazama Capital Management's HALO Position: Q1 2016 in Review

Mazama Capital Management sold out of Halozyme (HALO) in Q1 2016, closing a stake of 177,034 shares — an estimated $3.07M sold.

Mazama Capital Management first reported a position in HALO in Q2 2013 and held it in 9 quarters. The position peaked at $3.46M in Q4 2014. 161 funds tracked by Wall St. Rank hold HALO as of Q1 2016.

Mazama Capital Management reported no remaining Halozyme position as of Q1 2016 after selling out during the quarter.
Mazama Capital Management sold 177,034 Halozyme shares in Q1 2016, an estimated $3.07M.
Mazama Capital Management first reported a position in Halozyme in Q2 2013 and held it in 9 quarters.
Mazama Capital Management's Halozyme position peaked at $3.46M in Q4 2014.
161 funds tracked by Wall St. Rank held Halozyme as of Q1 2016.

Based on Mazama Capital Management's 13F filing for Q1 2016.